Cancer BiologybioRxivPreprint
CD44v6 Drives Tumor Aggressiveness and Chemoresistance in Bladder Cancer
Iris Lodewijk, Carolina Rubio, Pontus Eriksson…·Marta Dueñas
This study identifies CD44v6 as a driver of bladder cancer aggressiveness and chemoresistance, linking its expression to poor patient outcomes and therapeutic resistance.
DOI 10.1101/2025.08.27.672563